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Density and Mammographic Density?
A Systematic Review
Jong Min Lee, MPH,1 Susan Holley, MD,2 Catherine Appleton, MD,2 and Adetunji T. Toriola, MD, MPH, PhD1

Abstract

Introduction: Both bone mineral density (BMD) and breast density are related to reproductive hormone levels.
This suggests that BMD and breast density could be meaningfully associated, and serve as surrogate markers for
breast cancer risk. However, few studies have investigated the association of BMD with percent mammographic
density, making it difficult to draw meaningful conclusions.
Materials and Methods: We conducted a systematic review of studies published in electronic databases till
April 2016 using the following search terms: ‘‘bone density,’’ ‘‘bone mineral density,’’ ‘‘mammographic breast
density,’’ ‘‘breast density,’’ and ‘‘mammographic density.’’ We identified 203 articles, of which 8 met the
inclusion criteria for this review.
Results: BMD does not appear to be associated with percent mammographic density. BMD at the spine was
weakly positively associated with percent mammographic density among postmenopausal women who were not
hormone users, while BMD at the hip and legs was positively associated with percent mammographic density
among premenopausal women. On the other hand, one study reported an inverse association of BMD at the
spine and hip with percent mammographic density among perimenopausal women.
Conclusion: In this review, we found no evidence of an association between BMD and percent mammographic density.
Keywords: bone mineral density (BMD), mammographic density, menopause
Introduction

M

ammographic density is a strong risk factor for breast
cancer. An increased breast density is associated with a
four- to sixfold increased risk of breast cancer.1–4 Likewise,
some studies have suggested that increased bone mineral
density (BMD) might be associated with an increased risk of
breast cancer, especially among postmenopausal women.5,6
Although the underlying mechanisms are still poorly understood, hormonal exposure is thought to play an important role
in driving the association of mammographic density with
breast cancer risk.7–10 In the Women’s Health Initiative (WHI)
trial, 1 year of estrogen plus progestin use was associated with
a 6% increase in mammographic density.11 Hormonal exposure also plays an important role in BMD.12,13 Longer duration
of exposure to estrogen is positively associated with BMD.14–16
Estrogen deficiency during menopause induces cortical
bone loss by inhibiting bone resorption activity, resulting in

decreased bone mass.17–19 Hence, it is possible that similar
etiological pathways involving reproductive hormone exposure may drive the association of mammographic density and
BMD with breast cancer risk. On the other hand, adiposity,
which is a risk factor for postmenopausal breast cancer (but
inversely associated with premenopausal breast cancer), has
divergent effects on mammographic density and BMD.20,21
While body mass index (BMI) is positively associated with
BMD,22,23 it is inversely associated with mammographic
density.24,25 Therefore, the association of BMD with percent
mammographic density may be more complex.
Understanding the association of BMD with percent
mammographic density might provide better knowledge of
how breast cancer intermediaries increase breast cancer risk.
Furthermore, if mammographic density is associated with
BMD, knowing a woman’s breast density might have some
utility in predicting BMD, and possibly future fracture risk
since BMD is a strong predictor of future fracture risk.26 The
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few studies that have investigated the association of BMD
with percent mammographic density,27–34 have produced
conflicting results, and no review of the topic has been undertaken. To extend knowledge on the association of BMD
with percent mammographic density, we conducted a systematic review of published studies.
Materials and Methods

We identified studies published between January 2000 and
April 2016 using the following databases: PubMed, OVidSP,
BioMed Central, EMBASE, Web of Science, and Scopus.
Search terms included the following: ‘‘bone density,’’ ‘‘bone
mineral density,’’ ‘‘mammographic breast density,’’ ‘‘breast
density,’’ and ‘‘mammographic density.’’ Search queries in the
databases yielded 211 articles (Figure 1). Abstracts and results
were examined if the articles were relevant to our topic of
study. Reference lists of relevant articles were also examined.
From 211 articles, we included studies if they met the following criteria: reported on (1) the association of BMD with
percent mammographic density. Hence, studies using Breast
Imaging-Reporting and Data System (BI-RADS) classification
were not included. The exposure was defined as BMD, while
the outcome was defined as percent mammographic density.
(2) Publications were in English language. Eight studies met
the inclusion criteria. From these eight articles, we extracted
information on study design, age, menopausal status, and
number of participants, BMD sites, and confounders. Studies
were available on the following BMD sites in relation to
mammographic density: spine (N = 7), hip (N = 6), and other
sites, including arms, ribs, and overall body (N = 3). We extracted data on beta coefficient values, 95% confidence intervals (CIs), and p-values from the original studies.
Results
BMD at the spine

Seven studies have investigated the association of BMD at
the spine with percent mammographic density27–33 (Table 1).

FIG. 1. Flow diagram of
the literature search.

LEE ET AL.

No associations were reported in studies that did not stratify
by menopausal status. BMD of the spine was associated with
percent mammographic density in two studies of the five
studies that stratified by menopausal status. Crandall et al.
reported a very weak positive association between BMD at
the spine (b = 0.099, p = 0.08) and percent mammographic
density among postmenopausal women who were not recent
hormone users after adjusting for age, BMI, and cigarette
smoking.29 In another study, the same authors observed an
inverse association between BMD at the spine (b = -20.6
[95% CI: -37.2 to -3.9], p < 0.05) and mammographic density among early perimenopausal women.30
BMD at the hip

Six studies have investigated the association of BMD at the
hip with percent mammographic density27,29–33 (Table 2). The
studies that investigated associations among all women regardless of menopausal status reported no association.27,31,33
Five studies stratified their analyses by menopausal status.
BMD at the hip was positively associated with mammographic
density in two studies: one among premenopausal women
(b = 0.59, p < 0.05)33 and one among postmenopausal women
who were not recent hormone users (b = 0.156, p < 0.05).29
Conversely, an inverse association was observed among early
perimenopausal women (b = -18.8 [95% CI: -37.0 to -0.6],
p < 0.05).30
BMD at other sites (legs, ribs, arms, and whole body)

Only three studies have investigated the association of
BMD at other sites, including ribs, arms, leg, and whole body,
with mammographic density28,33,34 and two studies reported
no associations overall. However, Sung et al. observed a
positive association of BMD at the legs with mammographic
density among premenopausal women (b = 0.59, p < 0.05)33
(Table 3). A recent study observed a positive association of
BMD at the forearm with percent mammographic density

Table 1. Summary Description of Studies on the Association of Bone Mineral
Density at the Spine with Percent Mammographic Breast Density
Reference,
country
Sung et al.,33
Korea

Gupta et al.,32
Kuwait
Crandall et al.,30
United States

Dite et al.,27
Australia

Dite et al.,28
Australia

Design

Age
(years)

Cross-sectional

‡30

Study participants
Overall (N = 730)
Premenopausal
(N = 462)
Postmenopausal
(N = 268)

Cross-sectional 25–74 Premenopausal
(N = 147)
Postmenopausal
(N = 96)
Cross-sectional 42–52 Early
Perimenopausal
(N = 249)
Premenopausal
(N = 56)

Cross-sectional

Longitudinal

Overall (N = 268)
Premenopausal
(N = N/A)
Postmenopausal/past
or never HT
(N = N/A)
Postmenopausal/
current or recent
HT users
(N = N/A)
38–71 Overall (N = 134)
N/A

Crandall et al.,29 Cross-sectional 45–64 Postmenopausal
United States
women who are
not recent HT
users (N = 417)
Postmenopausal
women who are
recent HT users
(N = 173)
Kerlikowske
Cross-sectional ‡28 Overall (N = 405)
et al.,31
and nested
Premenopausal
United States
case-control
(N = 20)
study
Postmenopausal/past
or never HT
(N = 142)
Postmenopausal/
current or recent
HT (N = 153)
a

Results
(b coefficient
or correlation)
b = 0.27a
b = 0.21a
b = 0.42a

r = 0.158b
r = 0.021b

95%
Confidence
interval/p

Confounders

-0.01 to 0.55 Age, smoking status,
-0.0 to 0.46
alcohol
consumption,
physical exercise,
-0.27 to 1.11
number of live
children, age at
menarche, age at
birth of first child,
duration of breast
feeding, use of oral
contraceptives,
hormone
replacement therapy
0.125
Ethnicity
0.798

b = -20.6c

0.02

b = -29.0c

0.23

b = -0.02d
b = -0.10d

0.79
0.33

b = 0.02d

0.85

b = 0.24d

0.19

r = 0.015e

0.8

b = 0.099d

0.08

b = -0.065d

0.44

r = 0.01f
r = 0.09f

0.87
0.71

r = 0.06f

0.48

r = 0.00f

1.00

Age, BMI, ethnicity,
study site, number
of pregnancies,
alcohol
consumption, age at
first childbirth,
smoking status,
physical activity
score
Age, BMI, smoking
status

Age at mammogram,
age at bone scan,
height and weight
Age, BMI, smoking
status

Age, BMI, ethnicity,
age at first live
birth, HT use

Beta coefficients assessed by a linear mixed model.
Spearman’s correlation coefficient.
c
Beta coefficients assessed by a linear regression model. Current/recent hormone users were excluded in this model.
d
Beta coefficients assessed by a linear regression model.
e
Cross-trait cross-twin correlations.
f
Pearson’s correlation coefficient.
BMI, body mass index; HT, hormone therapy; N/A, not available.
b
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Table 2. Summary Description of Studies on the Association of Bone Mineral Density
at the Hip with Percent Mammographic Breast Density

Reference, country
Sung et al.,33
Korea

Gupta et al.,32
Kuwait
Crandall et al.,30
United States

Dite et al.,27
Australia

Crandall et al.,29
United States

Kerlikowske
et al.,31
United States

a

Design
Cross-sectional

Results
Age
(b coefficient or
(years) Study participants
correlation)
‡30

Overall (N = 730)
Premenopausal
(N = 462)
Postmenopausal
(N = 268)

Cross-sectional 25–74 Premenopausal
(N = 147)
Postmenopausal
(N = 96)
Cross-sectional 42–52 Early
Perimenopausal
(N = 301)
Premenopausal
(N = 80)

Overall (N = 268)
Premenopausal
(N = N/A)
Postmenopausal/
past or never HT
(N = N/A)
Postmenopausal/
current or recent
HT users
(N = N/A)
Cross-sectional 45–64 Postmenopausal
women who are
not recent HT
users (N = 417)
Postmenopausal
women who are
recent HT users
(N = 173)
Cross-sectional ‡28 Overall (N = 424)
Premenopausal
and nested
(N = 22)
case–control
study
Postmenopausal/
past or never HT
(N = 149)
Postmenopausal/
current or recent
HT (N = 158)
Cross-sectional

N/A

b = 0.75a
b = 0.59a
b = 0.45a

r = 0.094b
r = 0.082b

95%
Confidence
interval/p

Confounders

0.30 to 1.21 Age, smoking status,
alcohol
0.16 to 1.02
consumption,
physical exercise,
-0.46 to 1.36
number of live
children, age at
menarche, age at
birth of first child,
duration of breast
feeding, use of oral
contraceptives,
hormone
replacement
therapy
0.385
Ethnicity
0.342

b = -18.8c

0.04

b = 3.9c

0.87

b = -0.09d
b = -0.23d

0.41
0.06

b = 0.05d

0.78

b = -0.07d

0.79

b = 0.156d

0.04

b = -0.073d

0.51

r = -0.06e
r = -0.00e

0.22
1.00

r = -0.11e

0.17

r = -0.06e

0.47

Age, BMI, ethnicity,
study site, number
of pregnancies,
alcohol
consumption, age
at first childbirth,
smoking status,
physical activity
score
Age, BMI, and
smoking status

Age, BMI, smoking
status

Age, BMI, ethnicity,
age at first live
birth, HT use

Beta coefficients assessed by a linear mixed model.
Spearman’s correlation coefficient.
c
Beta coefficients assessed by a linear regression model. Current/recent hormone users were included in this model.
d
Beta coefficients assessed by a linear regression model.
e
Pearson’s correlation coefficient.
b
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Table 3. Summary Description of Studies on the Association of Bone Mineral Density
at Other Sites (Ribs, Arms, Body) with Percent Mammographic Breast Density
Reference,
country

Design

Moseson
et al.,34
Mexico

Prospective
cohort
study

Sung et al.,33 CrossKorea
sectional

Age
(years)
N/A

‡30

Premenopausal
(N = 955)

Forearm (BMD:
0.41–0.45): 0.2a
Forearm (BMD:
0.45–0.48): -0.91a
Forearm (BMD:
0.48+): -0.21a
Postmenopausal Forearm (BMD:
(N = 552)
0.35–0.40): 0.77a
Forearm (BMD:
0.40–0.44): 5.06a
Forearm (BMD:
0.44+): 4.44a
Overall (N = 730) Legs: b = 0.661

Premenopausal
(N = 462)
Postmenopausal
(N = 268)
Overall (N = 730)
Premenopausal
(N = 462)
Postmenopausal
(N = 268)
Overall (N = 730)
Premenopausal
(N = 462)
Postmenopausal
(N = 268)
Overall (N = 730)

28

Dite et al.,
Australia

Longitudinal

38–71

Results
(b coefficient
or correlation)

Study
participants

95%
Confidence
interval/p

Confounders

-2.30 to 2.71 Family history of breast
cancer, age at
menarche, smoking,
-3.42 to 1.61
alcohol, hormone use,
daily calcium intake,
-2.82 to 2.40
BMI, number of
pregnancies, age at
-2.32 to 3.86
first pregnancy,
contraceptive use
1.87 to 8.26
1.11 to 7.77

Ribs: b = 1.11a
Ribs: b = 0.59a

0.16 to 1.15 Age, smoking status,
alcohol consumption,
physical exercise,
0.05 to 1.14
number of live
children, age at
-0.51 to 1.28
menarche, age at
birth of first child,
0.28 to 1.57
duration of breast
-0.05 to 0.92
feeding, use of oral
contraceptives,
-0.09 to 3.82
hormone replacement
therapy
0.29 to 1.92
-0.07 to 1.24

Ribs: b = 0.91a

-1.53 to 3.36

Legs: b = 0.59a
Legs: b = 0.39a
Arms: b = 0.93a
Arms: b = 0.43a
Arms: b = 1.87a

-0.14 to 0.90

Whole body:
b = 0.381
Premenopausal
Whole body:
(N = 462)
b = 0.46a
Postmenopausal Whole body:
(N = 268)
b = 0.005a
Overall (N = 134) Arms: r = 0.0702

Overall (N = 134) Neck: r = -0.031

-0.10 to 1.03
-0.89 to 0.90
0.3
b

0.6

Age at mammogram,
age at bone scan,
height and weight

a

Beta coefficients assessed by a linear mixed model.
Cross-trait cross-twin correlations.
BMD, bone mineral density.

b

among postmenopausal women, but not among premenopausal women (Table 3).
Discussion

In this review, we identified eight studies published up till
April 2016 that evaluated the association of BMD with
percent mammographic density. There is little evidence to
support an association between BMD and percent mammographic density. However, there appears to be a weak
association between BMD at the spine and hip and percent
mammographic density, which may be modified by menopausal status. While BMD at the spine was weakly positively associated with percent mammographic density
among postmenopausal women who were not hormone
users, BMD at the spine and hip was weakly negatively
associated with mammographic density among perimeno-

pausal women. On the other hand, BMD at the hip and legs
was weakly positively associated with percent mammographic density among premenopausal women. Since reproductive hormone changes across a menstrual cycle as
well as across the menopausal transition,35 it is possible that
menopausal status, which affects reproductive hormone
levels, modifies the effect of BMD on percent mammographic density.
Hormonal status, BMD, and mammographic density

A few of the studies observed a small, but statistically significant association of BMD on percent mammographic density after stratifying by menopausal status. This suggests that
changes in reproductive hormone levels, particularly estrogen,
over the course of the reproductive life cycle might moderate
the association of BMD and percent mammographic density.
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Estrogen levels in women decrease with aging.36,37 The loss of
ovarian estrogen during menopause is associated with a decline in BMD.17,37 Postmenopausal women who use menopausal estrogen therapy for more than 7 years have higher
BMD than those who had not taken estrogen therapy.38 Furthermore, changes in reproductive hormones affect breast
density as well,7 although this appears mainly due to progesterone.11 This increase in percent mammographic density was
greater among postmenopausal women with the use of estrogen/progestin combination therapy, but not with the use of
estrogen only.39 Therefore, studies evaluating the associations
of BMD with mammographic density need to consider hormonal status, with respect to menopausal status and use of
menopausal hormonal therapy. Of the seven studies in this
review, only four stratified their analyses by both menopausal
status and use of menopausal hormonal therapy.27,29–31
Furthermore, because combined menopausal hormone
therapy (estrogen plus progestin) impacts breast density rather than estrogen alone, it is important for future studies to
specify what type of menopausal hormone therapy study
participants used.
BMI, BMD, and mammographic density

There is a complex relationship between adiposity, breast
cancer and breast cancer risk factors. Elevated BMI during
the premenopausal years has a protective effect on premenopausal breast cancer, but during the postmenopausal
years, elevated BMI is associated with increased breast
cancer risk.40,41 In addition, increased BMI is positively
associated with BMD, but inversely associated with mammographic density.42–44 For postmenopausal women, as
BMI increases, estrogen levels increase due to the conversion of androgens to estrogen in adipose tissue.45 In addition, a recently published study reported no association
overall, but a positive association between BMD and percent mammographic density among obese women, and an
inverse association among leaner women.34 This suggests a
complex association. Nevertheless, studies evaluating the
association of BMD with percent mammographic density
have not stratified their analyses by BMI, except for one
conducted among Kuwaiti women.32 It should be noted that
one study not included in this review, because it reported
breast density using the BI-RADS classification rather than
percent mammographic density, reported a small, but significant negative association between BMD at hip and breast
density among postmenopausal women with normal weight
and no relationship in overweight or obese women.46
Scattered fibroglandular densities and heterogeneously
dense categories have wide percent mammographic density
ranges and have large overlaps of percentage density in
qualitative BI-RADS categories 2–4, and this may introduce
limitations to their study.47,48
The limitations of this review need to be taken into consideration when interpreting the results. Because of the heterogeneity of studies and limited data on each BMD site, we
performed a systematic review, rather than a meta-analysis,
hence no additional statistical analyses were conducted.
In conclusion, there is no evidence to support an association between BMD and percent mammographic density. Any
potential association is weak at best, which argues against the
need for further studies.
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